Gilead's remdesivir is not recommended for patients hospitalized with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.
from CBC | Health News https://ift.tt/3lSxA9V
Aucun commentaire:
Enregistrer un commentaire